DONG RESEARCH GROUP

DRUG DISCOVERY & DELIVERY LABORATORY

Build & Design
Slide Background
Oval_1_1600x1200
previous arrowprevious arrow
next arrownext arrow

Welcome to Dong Research Group at Icahn School of Medicine at Mount Sinai

Our research is devoted to drug discovery and delivery for the treatment of genetic disorders, infectious diseases, and cancers. Together with our collaborators, we integrate our specialty in pharmaceutics, pharmaceutical chemistry, biomedical engineering, materials formulation, and animal studies to design novel therapeutic medicines and uncover their mechanisms of actions. The ultimate goal is to translate our scientific results and technological inventions into more effective treatments and more fulfilling lives of all individuals.

Lipid Nanoparticles

RNA Engineering

Cell Therapy

Mar 11, 2024– Our work on LNPs with polysarcosine lipids is accepted by Bioactive Materials. Congratulations Diana, Xucheng, and all the contributors!

Jan 15, 2024- Our work on stem cell engineering is accepted by Nature Communications. Congratulations Yonger, Yuebao, Yichen, and all the contributors!

Dec 12, 2023– Dr. Dong is inducted as a Fellow to the National Academy of Inventors. Congratulations!

Nov 13, 2023– Yonger successfully defended his dissertation thesis. Congratulations Dr. Xue!

Nov 02, 2023– Diana gave a research presentation at the NIH 2023 Synthetic Biology Consortium!

Sep 22, 2023– Xucheng presented our CATCH strategy for cancer immunotherapy at the 2023 PrIISM Retreat!

Jul 27, 2023– Our CATCH strategy for cancer immunotherapy is published on Nature Nanotechnology. Congratulations Yuebao, Xucheng, Shi, and all the contributors!

Jun 28, 2023– Our collaborative review article with the labs of Wei Tao and Daniel J. Siegwart is accepted by Nature Reviews Methods Primers. Congratulations to the collaborative teams!

Nov 01, 2022– Our lab moved to the Icahn School of Medicine at Mount Sinai!

Mar 25, 2022– Dr. Dong is inducted as a 2022 American Institute for Medical and Biological Engineering (AIMBE) Fellow

Zhang, Y., Hou, X., Du, S., Xue, Y., Yan, J., Kang, D., Zhong, Y., Wang, C., Deng, B., McComb, D., Dong, Y.*, Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy, Nature Nanotechnology, (2023).

Du, S., Zhang, Y., Li, W., Xue, Y., Hou, X., Yan, J., Cheng, J., Deng, B., McComb, D., Lin, J., Zeng, H., Cheng, X., Irvine, D., Weiss, R., Dong, Y.*, Cholesterol-Amino-Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self-Amplifying RNA and Restoration of Spermatogenesis in Infertile Mice, Advanced Science, (2023). 

Chen, S., Huang, X., Xue, Y., Benedicto, E., Shi, Y., Chen, W., Koo, S., Sigeward, D.*, Dong, Y.*, Tao, W.*, Nanotechnology-based mRNA vaccines, Nature Reviews Methods Primers,  (2023).

Hou, X., Zaks, T.*, Langer, R.*, Dong, Y.*, Lipid nanoparticles for mRNA delivery, Nature Reviews Materials, (2021).

Zhang, Y., Sun, C., Wang, C., Jankovic, K., Dong, Y.*, Lipids and Lipid Derivatives for RNA Delivery, Chemical Reviews, (2021).

Li, Y., Su, Z., Zhao, W., Zhang, X., Momin, N., Zhang, C., Wittrup, K.,  Dong, Y.*, Irvine, D*., Weiss, R*., Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity, Nature Cancer,  (2020).

Hou, X., Zhang, X., Zhao, W., Zeng, C., Deng, B., McComb, D. W., Du, S., Zhang, C., Li. W.,  Dong, Y.*, Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis, Nature Nanotechnology,  (2020).

Address

Icahn Genomics Institute

Precision Immunology Institute

Department of Immunology and Immunotherapy

Department of Oncological Sciences

Tisch Cancer Institute

Friedman Brain Institute

Icahn School of Medicine at Mount Sinai

1425 Madison Avenue, New York, NY, 10029 

Contact information

Email: yizhou.dong@mssm.edu

Quick links

Home

Research

Publications

Members

News

Resources

Join us